GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMF) » Definitions » Research & Development

Consort Medical (Consort Medical) Research & Development : $0.0 Mil (TTM As of Oct. 2019)


View and export this data going back to . Start your Free Trial

What is Consort Medical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Consort Medical's Research & Development for the six months ended in Oct. 2019 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2019 was $0.0 Mil.

Consort Medical Research & Development Historical Data

The historical data trend for Consort Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consort Medical Research & Development Chart

Consort Medical Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Consort Medical Semi-Annual Data
Apr10 Oct10 Apr11 Oct11 Apr12 Oct12 Apr13 Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Consort Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Consort Medical  (GREY:CSRMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Consort Medical Research & Development Related Terms

Thank you for viewing the detailed overview of Consort Medical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Consort Medical (Consort Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMF) » Definitions » Research & Development
Comparable Companies
SHSE:603987 ROCO:1565 LMAT SZSE:300061 TSE:7749 ATRS ROCO:8406 SGX:AP4 XSWX:CLTN SZSE:300753 SZSE:300358 SHSE:603301 LSE:AMS SZSE:300171 XKLS:7106 HKSE:01501 SHSE:603309 ANGO SZSE:300030 XKRX:039840
Traded in Other Exchanges
N/A
Address
Breakspear Way, Suite B Breakspear Park, Hemel Hempstead, Hertfordshire, GBR, HP2 4TZ
Website
https://www.consortmedical.com
Consort Medical PLC is part of the healthcare sector in the United Kingdom. It is one of the leading contract manufacturers in the field of drug delivery devices. Its core products include an inhaler, auto-injector, nasal and ocular technologies which it supplies to pharmaceutical companies. Along with devices, the company also specializes in drugs including active pharmaceutical ingredients and finished dose formulations.

Consort Medical (Consort Medical) Headlines

No Headlines